Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 117 * | Mon, 8/5/2013, 8:30 AM - 10:20 AM | CC-516a | |
| The Analysis of Recurrent Event Data in the Presence of Competing Risks and Informative Censoring — Topic Contributed Papers | |||
| Biopharmaceutical Section , SSC , Biometrics Section | |||
| Organizer(s): Byron Jones, Novartis Pharma AG | |||
| Chair(s): Byron Jones, Novartis Pharma AG | |||
| 8:35 AM | The Analysis of Recurrent Event Data in the Presence of Competing Risks and Informative Censoring — Lee-Jen Wei, Harvard University | ||
| 8:55 AM | Semiparametric Proportional Rate Regression for the Composite Endpoint of Recurrent and Terminal Events — Danyu Lin, Univ of North Carolina ; Lu Mao, The University of North Carolina | ||
| 9:15 AM | Recurrent Event Data Approaches in Cardiovascular Outcome Trials: A Case Study — Mouna Akacha, Novartis | ||
| 9:35 AM | The Role of Recurrent Event Analysis in Cardiovascular Trials: A Trialist's Perspective — Scott Solomon, Harvard University | ||
| 9:55 AM | Discussant: H. M. James Hung, PhD, U. S. Food and Drug Administration | ||
| 10:15 AM | Floor Discussion | ||
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.